Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Mersana Therapeutics Inc (NQ: MRSN )

16.65 USD -0.62 (-3.59%)
Official Closing Price Updated: 4:59 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 461,000
Open 17.41
Bid (Size) 16.65 (40)
Ask (Size) 16.66 (68)
Prev. Close 17.27
Today's Range 16.46 - 17.41
52wk Range 7.660 - 29.09
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting
From GlobeNewswire News Releases
Mersana Therapeutics to Host Conference Call and Webcast to Discuss the Selection of the NaPi2b Biomarker Cutoff and Commercial Diagnostic Development Path
Conference Call and webcast to be held on Friday, April 16, 2021, at 8:00 a.m. ET 
From GlobeNewswire News Releases

Performance

YTD
-37.22%
-37.22%
1 Month
-2.69%
-2.69%
3 Month
-23.17%
-23.17%
6 Month
-1.16%
-1.16%
1 Year
+83.77%
+83.77%

More News

Read More
Mersana Therapeutics Announces Initiation of UPLIFT Single-Arm Registration Strategy for UpRi in Platinum-Resistant Ovarian Cancer
From GlobeNewswire News Releases
Mersana Therapeutics Announces Publication of Two Manuscripts Detailing Preclinical Studies of the Dolaflexin Platform and Upifitamab Rilsodotin (XMT-1536) in AACR Journal Molecular Cancer Therapeutic
From GlobeNewswire News Releases
Mersana Therapeutics Announces Appointment of Allene Diaz to Board of Directors
From GlobeNewswire News Releases
Mersana Therapeutics to Present Three Posters at Upcoming Virtual 2021 American Association for Cancer Research Annual Meeting
From GlobeNewswire News Releases
Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2020 Financial Results and Business Updates
From GlobeNewswire News Releases
Mersana Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
From GlobeNewswire News Releases
Notable Wednesday Option Activity: MRSN, CAR, NRZ
Tags Stocks
From Market News Video
Mersana Therapeutics Starts UpRi Dosing In Heavily Pretreated Cohort Of Ovarian Cancer Patients
Tags Biotech Briefs Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.